BioCentury
ARTICLE | Company News

IsoTis restructuring

January 7, 2003 8:00 AM UTC

Tissue engineering company IsoTis (SWX:ISON; Euronext:ISON) said it will reduce headcount by 31% to about 107 FTEs and restructure its R&D in an effort to reduce its burn rate to EUR 14 million ($14.6...